Daniel J. Englander Named to Healthways Board of Directors

  Daniel J. Englander Named to Healthways Board of Directors

Business Wire

NASHVILLE, Tenn. -- March 17, 2014

The Board of Directors of Healthways(NASDAQ: HWAY), the largest independent
global provider of well-being improvement solutions, said today that it has
named Daniel J. Englander, founder and managing partner of Ursula Capital
Partners, as a Director. Mr. Englander will join the Board immediately and
also stand for election at the Company’s 2014 annual meeting.

“Dan brings an experienced independent investor and financial perspective to
our Board,” said John W. Ballantine, Chairman of the Healthways Board. “He has
been an investor in Healthways since 2005, knows our business well and
understands the markets for our well-being improvement solutions. We look
forward to working with him as he provides additional strategic, financial and
public markets insight into the Board’s deliberations.”

Mr. Englander, 44, founded Ursula Capital Partners, a New York City-based
investment firm, in 2004 and currently serves as its managing partner.
Previously, he served as a managing director and a partner with Allen &
Company, a New York City-based investment banking firm, where he served for
more than ten years. He currently also serves as a director at two public
companies, America’s Car-Mart, Inc. (NASDAQ: CRMT) and Copart, Inc. (NASDAQ:
CPRT). He holds a B.A. from Yale University.

About Healthways

Healthways is the largest independent global provider of well-being
improvement solutions. Dedicated to creating a healthier world one person at a
time, the Company uses the science of behavior change to produce and measure
positive change in well-being for our customers, which include employers,
integrated health systems, hospitals, physicians, health plans, communities
and government entities. We provide highly specific and personalized support
for each individual and their team of experts to optimize each participant’s
health and productivity and to reduce health-related costs. Results are
achieved by addressing longitudinal health risks and care needs of everyone in
a given population. The Company has scaled its proprietary technology
infrastructure and delivery capabilities developed over 30 years and now
serves approximately 45 million people on four continents. Learn more at
www.healthways.com.

Important Additional Information

Healthways, its directors and certain of its executive officers may be deemed
to be participants in the solicitation of proxies from Healthways stockholders
in connection with the matters to be considered at the Company's 2014 Annual
Meeting of Stockholders. Healthways intends to file a proxy statement with the
U.S. Securities and Exchange Commission (the "SEC") in connection with any
such solicitation of proxies from Healthways stockholders.INVESTORS AND
STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ ANY SUCH PROXY STATEMENT AND
ACCOMPANYING PROXY CARD AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND
IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT
INFORMATION. Detailed information regarding the identity of potential
participants, and their direct or indirect interests, by security holdings or
otherwise, will be set forth in the proxy statement and other materials to be
filed with the SEC in connection with the Company's 2014 Annual Meeting of
Stockholders. Information regarding the direct and indirect beneficial
ownership of the Company's directors and executive officers in Healthways
securities is included in their SEC filings on Forms 3, 4 and 5, and
additional information can also be found in the Company's Annual Report on
Form 10-K for the year ended December 31, 2013, filed with the SEC on March
14, 2014. Stockholders will be able to obtain any proxy statement, any
amendments or supplements to the proxy statement and other documents filed by
Healthways with the SEC for no charge at the SEC's website atwww.sec.gov.
Copies will also be available at no charge at the Investor Relations section
of our corporate website atwww.healthways.com.

Contact:

Healthways
Investor Relations Contact:
Chip Wochomurka, 615-614-4493
chip.wochomurka@healthways.com
 
Press spacebar to pause and continue. Press esc to stop.